JP2024077661A - Skin cosmetic composition - Google Patents
Skin cosmetic composition Download PDFInfo
- Publication number
- JP2024077661A JP2024077661A JP2022189734A JP2022189734A JP2024077661A JP 2024077661 A JP2024077661 A JP 2024077661A JP 2022189734 A JP2022189734 A JP 2022189734A JP 2022189734 A JP2022189734 A JP 2022189734A JP 2024077661 A JP2024077661 A JP 2024077661A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- extract
- points
- cosmetic composition
- skin cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 55
- 239000002537 cosmetic Substances 0.000 title claims abstract description 48
- 239000000284 extract Substances 0.000 claims abstract description 68
- 241001105098 Angelica keiskei Species 0.000 claims abstract description 19
- 241000951471 Citrus junos Species 0.000 claims abstract description 19
- CAKGLMPBYAPFCR-UWBMNBDUSA-N Bemisiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 CAKGLMPBYAPFCR-UWBMNBDUSA-N 0.000 claims abstract description 18
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 18
- 239000004480 active ingredient Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 83
- 230000000694 effects Effects 0.000 description 33
- 238000011156 evaluation Methods 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 23
- 239000007788 liquid Substances 0.000 description 21
- 230000003020 moisturizing effect Effects 0.000 description 17
- 230000004888 barrier function Effects 0.000 description 16
- 230000007306 turnover Effects 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 210000000434 stratum corneum Anatomy 0.000 description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 238000010606 normalization Methods 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 229920002125 Sokalan® Polymers 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 239000006071 cream Substances 0.000 description 8
- 210000000245 forearm Anatomy 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- -1 ethanol Chemical compound 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 229940073665 octyldodecyl myristate Drugs 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 3
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000003822 cell turnover Effects 0.000 description 3
- 229940106189 ceramide Drugs 0.000 description 3
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940124274 edetate disodium Drugs 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- PXGZQGDTEZPERC-UHFFFAOYSA-N 1,4-cyclohexanedicarboxylic acid Chemical compound OC(=O)C1CCC(C(O)=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 2
- 229920000298 Cellophane Polymers 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- 240000003538 Chamaemelum nobile Species 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 229940031722 methyl gluceth-20 Drugs 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- AOHAPDDBNAPPIN-UHFFFAOYSA-N myristicinic acid Natural products COC1=CC(C(O)=O)=CC2=C1OCO2 AOHAPDDBNAPPIN-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229940057874 phenyl trimethicone Drugs 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 2
- WHNXAQZPEBNFBC-UHFFFAOYSA-K trisodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(2-hydroxyethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].OCCN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O WHNXAQZPEBNFBC-UHFFFAOYSA-K 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- OWTXHZITCDRRTI-UHFFFAOYSA-N 3-cyclohexyloxypropane-1,2-diol Chemical compound OCC(O)COC1CCCCC1 OWTXHZITCDRRTI-UHFFFAOYSA-N 0.000 description 1
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 1
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 241000544270 Angelica acutiloba Species 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 235000001553 Betula platyphylla Nutrition 0.000 description 1
- 241001313086 Betula platyphylla Species 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 240000008669 Hedera helix Species 0.000 description 1
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 235000011925 Passiflora alata Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 240000008440 Passiflora incarnata Species 0.000 description 1
- 235000011922 Passiflora incarnata Nutrition 0.000 description 1
- 235000013750 Passiflora mixta Nutrition 0.000 description 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 240000006694 Stellaria media Species 0.000 description 1
- 235000017860 Tilia japonica Nutrition 0.000 description 1
- 240000001142 Tilia japonica Species 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- OOHTWBUKWQKKEE-UHFFFAOYSA-N [6-(diethylamino)-6-hydroxy-7-oxo-7-phenylheptyl] benzoate Chemical compound C=1C=CC=CC=1C(=O)C(O)(N(CC)CC)CCCCCOC(=O)C1=CC=CC=C1 OOHTWBUKWQKKEE-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940054264 alaria esculenta extract Drugs 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 1
- 229940069638 aloe vera leaf extract Drugs 0.000 description 1
- 229940064062 alpha-glucan oligosaccharide Drugs 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- 229940119162 calendula officinalis flower extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- PXGZQGDTEZPERC-UHFFFAOYSA-L cyclohexane-1,4-dicarboxylate Chemical compound [O-]C(=O)C1CCC(C([O-])=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-L 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- VJZWIFWPGRIJSN-XRHABHTOSA-N dilinoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O.CCCCC\C=C/C\C=C/CCCCCCCC(O)=O VJZWIFWPGRIJSN-XRHABHTOSA-N 0.000 description 1
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- AMQDHYXCJCIBQJ-YCWPWOODSA-L disodium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-oxido-5-oxo-2h-furan-4-yl] sulfate Chemical compound [Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OS([O-])(=O)=O)=C1[O-] AMQDHYXCJCIBQJ-YCWPWOODSA-L 0.000 description 1
- 229940102552 disteardimonium hectorite Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000002305 glucosylceramides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 description 1
- 229940082431 hamamelis virginiana leaf extract Drugs 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 229940055350 kiwi fruit extract Drugs 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940051810 licorice root extract Drugs 0.000 description 1
- 235000020725 licorice root extract Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000015206 pear juice Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940074113 rosa multiflora fruit extract Drugs 0.000 description 1
- 239000008132 rose water Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 229940080236 sodium cetyl sulfate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229940045898 sodium stearoyl glutamate Drugs 0.000 description 1
- KDHFCTLPQJQDQI-BDQAORGHSA-M sodium;(4s)-4-amino-5-octadecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KDHFCTLPQJQDQI-BDQAORGHSA-M 0.000 description 1
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 1
- QKHBMQWPOUUMQZ-BDQAORGHSA-M sodium;hydron;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC([O-])=O QKHBMQWPOUUMQZ-BDQAORGHSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940057429 sorbitan isostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940092665 tea leaf extract Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 125000000647 trehalose group Chemical group 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は皮膚化粧料組成物に関し、詳細には、保湿効果及び肌の赤み改善に優れながらも、べたつきを抑え、ターンオーバーの正常化やバリア機能の向上に寄与する皮膚化粧料組成物に関するものである。 The present invention relates to a skin cosmetic composition, and more specifically, to a skin cosmetic composition that has excellent moisturizing effects and reduces redness of the skin, while suppressing stickiness, and contributes to normalizing cell turnover and improving the skin barrier function.
現在、敏感肌や乾燥肌にも優しく使用できることを期待して、植物抽出物や多糖類、アミノ酸など、低刺激や刺激緩和、抗炎症などの性質をもつ種々の天然由来成分を配合した皮膚化粧料が紹介されている。 Currently, skin cosmetics containing various naturally derived ingredients such as plant extracts, polysaccharides, and amino acids that have low irritation, irritation-relieving, and anti-inflammatory properties are being introduced with the expectation that they can be used gently on sensitive or dry skin.
例えば、保湿効果に優れる天然由来成分としてワレモコウが挙げられる(例えば特許文献1、2)が、化粧料に配合した際の使用感としてべたつきなど使用感を低下させることがあった。 For example, Sanguinea oleracea is a naturally derived ingredient with excellent moisturizing effects (e.g., Patent Documents 1 and 2). However, when incorporated into cosmetics, it can cause stickiness and other issues that reduce the feel when used.
また肌の赤みを改善する天然由来成分としてトケイソウが挙げられる(例えば特許文献3)が、化粧料に配合した際の使用感としてべたつきなど使用感を低下させることがあった。 Passionflower is also known as a naturally derived ingredient that reduces redness in the skin (e.g., Patent Document 3), but when added to cosmetics, it can cause stickiness and other issues that reduce the feel when used.
そのため、天然由来成分を用いて、保湿効果や肌の赤みを抑制する効果を得ながらも、べたつきなどの使用感を低下させない皮膚化粧料が強く望まれていた。 Therefore, there has been a strong demand for skin cosmetics that use naturally derived ingredients to provide moisturizing effects and suppress redness of the skin, while not compromising the feel of use, such as stickiness.
本発明は、上記課題を鑑みてなされたものであり、その目的は保湿効果及び肌の赤み改善に優れながらもべたつきも抑えられる皮膚化粧料組成物及び皮膚化粧料用べたつき抑制剤を提供することを課題とする。 The present invention was made in consideration of the above problems, and its objective is to provide a skin cosmetic composition and a stickiness suppressant for skin cosmetics that have excellent moisturizing effects and reduce skin redness while also suppressing stickiness.
本発明者らは上記課題を解決するため鋭意研究を行った結果、アシタバ抽出物、ユズ果実抽出物、グルコシルトレハロースを組み合わせることによって、保湿効果及び肌の赤み改善に優れながらもべたつきも抑えられる皮膚化粧料組成物を見出し、本発明を完成した。 As a result of intensive research conducted by the inventors to solve the above problems, they discovered a skin cosmetic composition that combines Angelica keiskei extract, yuzu fruit extract, and glucosyl trehalose to provide excellent moisturizing effects and reduce skin redness while also reducing stickiness, thus completing the present invention.
第1の発明は、
下記成分(A)~(C)を含有する皮膚化粧料組成物である。
(A)アシタバ抽出物
(B)ユズ果実抽出物
(C)グルコシルトレハロース
第2の発明は、
前記(A)及び(B)に対する(C)の配合量((C)/(A+B))が0.25以上である皮膚化粧料組成物である。
第3の発明は、
前記(C)成分を有効成分とする前記(A)及び/又は前記(B)の皮膚化粧料用べたつき抑制剤である。
The first invention is
The skin cosmetic composition contains the following components (A) to (C):
(A) Angelica keiskei extract (B) Yuzu fruit extract (C) Glucosyl trehalose The second invention is
In the skin cosmetic composition, the blending amount of (C) relative to (A) and (B), ((C)/(A+B)), is 0.25 or more.
The third invention is
The stickiness-reducing agent for skin cosmetics of (A) and/or (B) contains the component (C) as an active ingredient.
本発明により、保湿効果及び肌の赤み改善に優れながらもべたつきを抑えられる皮膚化粧料組成物及び皮膚化粧料用べたつき抑制剤を提供することができる。さらに驚くべきことに、本発明に係る皮膚化粧料組成物には、ターンオーバーの正常化やバリア機能の向上にも寄与することを見出した。 The present invention provides a skin cosmetic composition and a stickiness inhibitor for skin cosmetics that are excellent in moisturizing effect and reducing redness of the skin while suppressing stickiness. Even more surprisingly, it has been found that the skin cosmetic composition of the present invention also contributes to normalizing cell turnover and improving the barrier function.
以下、本発明の構成について詳述する。本発明の皮膚化粧料組成物は、以下に詳述する成分(A)アシタバ抽出物(B)ユズ果実抽出物(C)グルコシルトレハロースを含有することにより、本発明の効果を発揮することができる。 The composition of the present invention will be described in detail below. The skin cosmetic composition of the present invention can exert the effects of the present invention by containing the following components: (A) Angelica keiskei extract, (B) Yuzu fruit extract, and (C) glucosyl trehalose.
本明細書において、「肌の赤み」とは、炎症を抑制するために毛細血管が拡張し、血流量が増えることで生じる赤みをいう。また「ターンオーバー」とは、一定のサイクルで表皮の細胞が生まれ変わることを指す言葉であり、具体的には、基底層で作られた基底細胞が分裂し、肌の表面に向かって押し上げられ、その後垢となって脱落するというサイクルである。このサイクルが繰り返されることで、皮膚のバリア機能などが保たれ、すこやかで美しい肌状態を維持することができている。一方、加齢、乾燥、紫外線等の影響によりターンオーバーが乱れ角層細胞の形成や細胞間脂質の構造に異常が生じることが考えられる。そして、様々な皮膚疾患や肌荒れ等の皮膚トラブルを生じることが知られている。「ターンオーバー正常化」とは、このようにターンオーバーが乱れた状態の皮膚を正常化することを意味する。また、「みずみずしさ」とは、皮膚化粧料組成物を使用した後、手で肌を触った際にぬるつきがなくしっとりとしており、油膜感がなくうるおいを感じられ、かつ外観が自然な光沢があり明るく、健康そうに見えると定義する。 In this specification, "skin redness" refers to redness caused by capillary expansion and increased blood flow to suppress inflammation. "Turnover" refers to the regeneration of epidermal cells in a certain cycle, specifically, the cycle in which basal cells produced in the basal layer divide, are pushed up toward the surface of the skin, and then become dandruff and fall off. This cycle is repeated to maintain the barrier function of the skin and maintain a healthy and beautiful skin condition. On the other hand, it is thought that turnover is disrupted due to the effects of aging, dryness, ultraviolet rays, etc., causing abnormalities in the formation of stratum corneum cells and the structure of intercellular lipids. It is known that this causes various skin diseases and skin troubles such as rough skin. "Normalizing turnover" means normalizing skin in such a state of disrupted turnover. "Moisture" is defined as the feeling of being moist and not sticky when touched with the hand after using the skin cosmetic composition, feeling moist without an oily film feeling, and having a natural glossy, bright, and healthy appearance.
<(A)アシタバ抽出物>
本発明の皮膚化粧料組成物で用いられる(A)成分はアシタバ抽出物である。アシタバ抽出物は、アシタバ(Angelica keiskei)から抽出された抽出物であり、そのまま又は粉砕後、水、エタノール等の低級アルコール、プロピレングリコールや1,3-ブチレングリコール等の多価アルコール、ジエチレングリコールエーテル等の多価アルコールアルキルエーテルその他の極性溶媒、又はそれらの混液にて抽出して得ることができるが、これらに限定されるものではない。また、アシタバ抽出物は、アシタバの葉及び茎を抽出したものが望ましいが、これらに限定されるものではない。
<(A) Angelica keiskei extract>
The component (A) used in the skin cosmetic composition of the present invention is an extract of Angelica keiskei. The extract of Angelica keiskei is an extract extracted from Angelica keiskei, and can be obtained by extracting the plant as is or after crushing with water, a lower alcohol such as ethanol, a polyhydric alcohol such as propylene glycol or 1,3-butylene glycol, a polyhydric alcohol alkyl ether such as diethylene glycol ether, or other polar solvent, or a mixture thereof, but is not limited thereto. In addition, the extract of Angelica keiskei is preferably an extract of the leaves and stems of Angelica keiskei, but is not limited thereto.
これらの成分は市販されている化粧品原料として入手可能である。市販品としては、「アシタバ抽出液BG(香栄興業株式会社製)」、「ファルコレックス アシタバ B(一丸ファルコス株式会社製)」、「和ism<アシタバ>(丸善製薬株式会社製)」、「アシタバエキス-BG(株式会社ヤマダ薬研製)」を例示できる。 These ingredients are available as commercially available cosmetic ingredients. Examples of commercially available products include "Ashitaba Extract BG (manufactured by Koei Kogyo Co., Ltd.)", "Falcorex Ashitaba B (manufactured by Ichimaru Pharcos Co., Ltd.)", "Waism <Ashitaba> (manufactured by Maruzen Pharmaceutical Co., Ltd.)" and "Ashitaba Extract BG (manufactured by Yamada Yaken Co., Ltd.)".
アシタバ抽出部は、保湿、ヒアルロン酸産生促進、コラーゲン産生促進、抗酸化作用を有することが知られているが、本発明では、さらにターンオーバー正常化作用も有し、バリア機能向上に寄与することを見出した。 Angelica keiskei extract is known to have moisturizing properties, promote hyaluronic acid production, promote collagen production, and have antioxidant properties, but in this invention, it has been discovered that it also has a turnover normalizing effect, contributing to improved barrier function.
(A)成分の配合量は、皮膚化粧料組成物全体質量中好ましくは0.001%~3%であり、より好ましくは0.005%~1%である。0.001%以上であれば十分な保湿効果を得られ、またターンオーバー正常化に適している。一方、3%以下であれば後述の(C)成分と組み合わせることでべたつきを抑制することができる。 The blending amount of component (A) is preferably 0.001% to 3% of the total weight of the skin cosmetic composition, and more preferably 0.005% to 1%. If it is 0.001% or more, a sufficient moisturizing effect is obtained and it is also suitable for normalizing cell turnover. On the other hand, if it is 3% or less, stickiness can be suppressed by combining it with component (C) described below.
<(B)ユズ果実抽出物>
本発明の皮膚化粧料組成物で用いられる(B)成分はユズ果実抽出物である。ユズ果実抽出物はユズ(Citrus junos)の果実から抽出された抽出物であり、そのまま又は粉砕後、水、エタノール等の低級アルコール、プロピレングリコールや1,3-ブチレングリコール等の多価アルコール、ジエチレングリコールエーテル等の多価アルコールアルキルエーテルその他の極性溶媒、又はそれらの混液にて抽出して得ることができるが、これらに限定されるものではない。
<(B) Yuzu Fruit Extract>
Component (B) used in the skin cosmetic composition of the present invention is a yuzu fruit extract. The yuzu fruit extract is an extract extracted from the fruit of yuzu (Citrus junos), and can be obtained by extracting the fruit, either directly or after crushing, with water, a lower alcohol such as ethanol, a polyhydric alcohol such as propylene glycol or 1,3-butylene glycol, a polyhydric alcohol alkyl ether such as diethylene glycol ether, or other polar solvents, or mixtures thereof, but is not limited thereto.
これらの成分は市販されている化粧品原料として入手可能である。市販品としては、「ファルコレックス ユズ E(一丸ファルコス株式会社製)」、「ユズセラミド B(一丸ファルコス株式会社製)」、「和ism<土佐ユズ>(丸善製薬株式会社製)」、「ユズ抽出液-J(丸善製薬株式会社製)」を例示できる。 These ingredients are available as commercially available cosmetic ingredients. Examples of commercially available products include "Falcorex Yuzu E (manufactured by Ichimaru Pharcos Co., Ltd.)", "Yuzu Ceramide B (manufactured by Ichimaru Pharcos Co., Ltd.)", "Waism <Tosa Yuzu> (manufactured by Maruzen Pharmaceutical Co., Ltd.)", and "Yuzu Extract-J (manufactured by Maruzen Pharmaceutical Co., Ltd.)".
ユズ果実抽出部は、収れん、保湿、血行促進作用を有することが知られているが、本発明では、肌の赤み改善目的で使用される。 Yuzu fruit extract is known to have astringent, moisturizing, and blood circulation promoting effects, but in the present invention it is used to improve skin redness.
本発明の皮膚化粧料組成物に用いる成分(B)の配合量は、好ましくは0.001%~3%であり、より好ましくは0.005%~1%である。0.001%以上であれば肌の赤みを改善でき、3%以下であれば後述の(C)成分と組み合わせることでべたつきを抑制することができる。 The amount of component (B) used in the skin cosmetic composition of the present invention is preferably 0.001% to 3%, and more preferably 0.005% to 1%. If it is 0.001% or more, redness of the skin can be improved, and if it is 3% or less, stickiness can be suppressed by combining it with component (C) described below.
<(C)グルコシルトレハロース>
本発明の皮膚化粧料組成物で用いられる(C)成分は、グルコシルトレハロースである。グルコシルトレハロースは、トレハロースにグルコースが1~3個結合した構造をもつ、非還元性の糖質である。これらの成分は市販されている化粧品原料として入手可能である。市販品としては、「トルナーレ(株式会社林原製)」を例示できる。
<(C) Glucosyltrehalose>
The component (C) used in the skin cosmetic composition of the present invention is glucosyltrehalose. Glucosyltrehalose is a non-reducing carbohydrate having a structure in which 1 to 3 glucose units are bound to trehalose. These components are available as commercially available cosmetic raw materials. An example of a commercially available product is "Tornale (manufactured by Hayashibara Co., Ltd.").
グルコシルトレハロースは、結合剤、乳化安定剤、皮膜形成剤、保水剤、皮膚保護剤として用いられることが知られているが、本発明ではグルコシルトレハロースが、(A)成分と(B)成分によるべたつきを抑制することを見出した。 Glucosyltrehalose is known to be used as a binder, emulsion stabilizer, film former, moisturizer, and skin protectant, but in the present invention, it has been found that glucosyltrehalose suppresses stickiness caused by components (A) and (B).
さらに驚くべきことに、本発明では、グルコシルトレハロース単独ではバリア機能向上は望めないが、(A)成分にグルコシルトレハロースを加えることで、(A)によるバリア機能が相乗的に向上することを見出した。 More surprisingly, in the present invention, it was found that while glucosyltrehalose alone does not improve the barrier function, adding glucosyltrehalose to component (A) synergistically improves the barrier function of (A).
(C)成分の配合量は、好ましくは0.001%~3%であり、より好ましくは0.005%~1%である。0.001%以上であれば(A)成分と(B)成分によるべたつきを抑制することができ、3%以下であれば塗布中に(C)成分によるヨレを生じない。 The amount of component (C) is preferably 0.001% to 3%, and more preferably 0.005% to 1%. If it is 0.001% or more, the stickiness caused by components (A) and (B) can be suppressed, and if it is 3% or less, the component (C) will not cause wrinkling during application.
また(A)成分と(B)成分の配合量に対する(C)成分の配合量((C)/(A+B))は0.25以上であることが好ましい。0.25以上であれば、(A)成分と(B)成分の併用によって生じるべたつきを改善することができる。 The ratio of the amount of component (C) to the amount of components (A) and (B) ((C)/(A+B)) is preferably 0.25 or more. If it is 0.25 or more, the stickiness caused by the combined use of components (A) and (B) can be improved.
<その他の成分>
本発明の皮膚化粧料組成物は、上述した成分の他に、本発明の目的を損なわない範囲で、他の成分、例えば、陰イオン性界面活性剤、陽イオン性界面活性剤、両性界面活性剤、非イオン性界面活性剤、油剤、高分子化合物、増粘剤、粉体(色素、樹脂、顔料)、防腐剤、香料、保湿剤、生理活性成分、ミネラル塩類、溶媒、酸化防止剤、キレート剤、パール化剤、中和剤、pH調整剤、本発明の皮膚化粧料組成物で用いられる成分(C)に記載
以外の植物エキス、酵素等の成分を適宜配合することができる。
<Other ingredients>
In addition to the components described above, the skin cosmetic composition of the present invention may contain other components, such as anionic surfactants, cationic surfactants, amphoteric surfactants, nonionic surfactants, oils, polymeric compounds, thickeners, powders (colorants, resins, pigments), preservatives, fragrances, moisturizers, physiologically active ingredients, mineral salts, solvents, antioxidants, chelating agents, pearlizing agents, neutralizing agents, pH adjusters, plant extracts other than those listed under component (C) used in the skin cosmetic composition of the present invention, enzymes, and the like, as appropriate, within the scope of the object of the present invention.
また、本発明の皮膚化粧料組成物には、本発明の目的を損なわない範囲で、生理活性成分を適宜配合することができる。生理活性物質とは、皮膚に塗布した場合に皮膚に何らかの生理活性を与える物質であり、例えば、抗炎症剤、老化防止剤、紫外線防御剤、収斂剤、抗酸化剤、血行促進剤、抗菌剤、殺菌剤、乾燥剤、冷感剤、温感剤、ビタミン類、アミノ酸、創傷治癒促進剤、刺激緩和剤、鎮痛剤、細胞賦活剤等が挙げられる。 The skin cosmetic composition of the present invention may also contain a suitable amount of physiologically active ingredients, provided that the purpose of the present invention is not impaired. A physiologically active substance is a substance that imparts some physiological activity to the skin when applied to the skin, and examples of such substances include anti-inflammatory agents, anti-aging agents, UV protection agents, astringents, antioxidants, blood circulation promoters, antibacterial agents, germicides, drying agents, cooling agents, warming agents, vitamins, amino acids, wound healing promoters, irritation mitigators, analgesics, and cell activators.
<皮膚化粧料>
本発明の皮膚化粧料組成物は、常法に従って製造することができる。また、本発明の皮膚化粧料組成物の一例としては、ローション、乳液、クリーム、ジェル、セラム、シートマスク、メイク、ボデイローション、ボディジェル、ボディクリーム、化粧下地等が挙げられる。剤形も目的に応じて任意に選択することができる。すなわち、液状、クリーム状、ジェル状、乳液状、シート状、スティック状、エアゾール状等のものが挙げられる。本発明の皮膚化粧料組成物は、一般の化粧料に限定されるものではなく、医薬部外品、指定医薬部外品、外用医薬品等を包含するものである。
<Skin cosmetics>
The skin cosmetic composition of the present invention can be produced according to a conventional method. Examples of the skin cosmetic composition of the present invention include lotions, milky lotions, creams, gels, serums, sheet masks, makeup, body lotions, body gels, body creams, makeup bases, etc. The dosage form can also be selected arbitrarily depending on the purpose. That is, examples include liquids, creams, gels, milky lotions, sheets, sticks, aerosols, etc. The skin cosmetic composition of the present invention is not limited to general cosmetics, but includes quasi-drugs, designated quasi-drugs, external medicines, etc.
次に本発明を実施例に基づいて詳細に説明するが、これに限定されるものではない。実施例に先立ち、各実施例で採用した試験法、評価法を説明する。 Next, the present invention will be described in detail based on examples, but the present invention is not limited to these. Prior to the examples, the test methods and evaluation methods used in each example will be explained.
1.べたつきのなさ評価試験
専門パネル10名により、前腕部をぬるま湯で洗浄したのち、それぞれ温度25℃、相対湿度50%の環境下にて20分間馴化させた。その後、本発明の実施例および比較例の皮膚化粧料組成物を適量塗布し、使用中および使用後の肌のべたつきについて下記の評点のつけ方にて官能評価を実施した。評価基準は、5名のべたつきのなさに関する評点を合計した値の平均値を用いて、以下の通りに分類した。
<べたつきのなさに関する評点と内容>
5点・・・使用中および使用後において肌のべたつきを感じない。
4点・・・使用中および使用後において肌のべたつきをわずかに感じる。
3点・・・使用中および使用後において肌のべたつきをやや感じる。
2点・・・使用中および使用後において肌のべたつきを感じる。
1点・・・使用中および使用後において肌のべたつきを強く感じ、不快である。
(べたつきのなさの評価基準)
◎:極めて良好 (5名の平均点が4点以上であった)
○:良好 (5名の平均点が3点以上、4点未満であった)
△:やや悪い (5名の平均点が2点以上、3点未満であった)
×:悪い (5名の平均点が2点未満であった)
1. Evaluation test for non-stickiness Ten expert panelists washed their forearms with lukewarm water, and then allowed them to acclimate for 20 minutes in an environment with a temperature of 25°C and a relative humidity of 50%. Then, appropriate amounts of the skin cosmetic compositions of the examples and comparative examples of the present invention were applied, and a sensory evaluation was performed on the stickiness of the skin during and after use, using the following rating system. The evaluation criteria were classified as follows, using the average value of the total ratings for non-stickiness given by five panelists.
<Scores and details regarding non-stickiness>
5 points: Skin does not feel sticky during or after use.
4 points: Skin feels slightly sticky during and after use.
3 points: Skin feels slightly sticky during and after use.
2 points: Skin feels sticky during and after use.
1 point: The skin feels very sticky during and after use, which is uncomfortable.
(Evaluation criteria for non-stickiness)
◎: Very good (average score of 5 people was 4 points or more)
○: Good (the average score of the five participants was 3 points or more and less than 4 points)
△: Somewhat poor (the average score of the five participants was 2 points or more but less than 3 points)
×: Poor (the average score of 5 people was less than 2 points)
2.肌のうるおいの評価試験
評価パネル10名について、前腕部をぬるま湯で洗浄したのち、それぞれ温度25℃、相対湿度50%の環境下にて20分間馴化させた。その後、本発明の実施例および比較例の皮膚化粧料組成物を適量塗布し、ふたたび温度25℃、相対湿度50%の環境下にて20分間馴化後、角質水分量(コンダクタンス値)をCorneometer(MPA580、Courage+Khazaka社製)を用いて測定した。うるおい効果の評価は、以下の計算式よりうるおい効果(%)を算出して5名の平均値を求め、下記判断基準に基づいて行った。
<肌のうるおい効果に関する評点>
うるおい効果(%)=(塗布後の肌の角質水分量/塗布前の角質水分量)×100
(肌のうるおい効果の評価基準)
◎:うるおい効果(%)が150%以上であった。
○:うるおい効果(%)が125%以上150%未満であった。
△:うるおい効果(%)が100%以上125%未満であった。
×:うるおい効果(%)が100%未満であった。
2. Skin Moisture Evaluation Test The forearms of 10 evaluation panelists were washed with lukewarm water, and then allowed to acclimate for 20 minutes in an environment with a temperature of 25°C and a relative humidity of 50%. Then, an appropriate amount of the skin cosmetic composition of the present invention and the comparative example was applied, and the skin was allowed to acclimate for 20 minutes again in an environment with a temperature of 25°C and a relative humidity of 50%, after which the stratum corneum moisture content (conductance value) was measured using a Corneometer (MPA580, Courage+Khazaka). The moisturizing effect was evaluated by calculating the moisturizing effect (%) from the following formula, averaging the values of the five panelists, and based on the following criteria.
<Skin moisturizing effect rating>
Moisture effect (%) = (skin moisture content of stratum corneum after application / skin moisture content of stratum corneum before application) x 100
(Evaluation criteria for skin moisturizing effect)
⊚: Moisturizing effect (%) was 150% or more.
Good: The moisturizing effect (%) was 125% or more and less than 150%.
Δ: Moisturizing effect (%) was 100% or more and less than 125%.
×: Moisturizing effect (%) was less than 100%.
3.肌のみずみずしさの評価試験
評価パネル10名について、前腕部をぬるま湯で洗浄したのち、それぞれ温度25℃、相対湿度50%の環境下にて20分間馴化させた。その後、本発明の実施例および比較例の皮膚化粧料組成物を適量塗布し、ふたたび温度25℃、相対湿度50%の環境下にて20分間馴化後、肌のみずみずしさについて下記の評点のつけ方にて官能評価を実施した。肌のみずみずしさに関する評価は、以下に示す評価基準にもとづいて、5名の評点を合計した値の平均値を用いて、以下の通りに分類した。
<肌のみずみずしさに関する評点と内容>
5点・・・肌が非常にみずみずしく、しっとりしていると感じる。
4点・・・肌がややみずみずしい。
3点・・・どちらともいえない。
2点・・・肌はややみずみずしくない。
1点・・・肌がみずみずしくなく、しっとりしているとまったく感じない。
(肌のみずみずしさの評価基準)
◎:極めて良好 (5名の平均点が4点以上であった)
○:良好 (5名の平均点が3点以上、4点未満であった)
△:やや悪い (5名の平均点が2点以上、3点未満であった)
×:悪い (5名の平均点が2点未満であった)
3. Evaluation test of skin moisture After washing the forearms of 10 evaluation panelists with lukewarm water, each was allowed to acclimate for 20 minutes in an environment at a temperature of 25°C and a relative humidity of 50%. Then, an appropriate amount of the skin cosmetic composition of the present invention and the comparative example was applied, and after acclimatization for 20 minutes again in an environment at a temperature of 25°C and a relative humidity of 50%, a sensory evaluation of skin moisture was performed using the following scoring method. The evaluation of skin moisture was classified as follows, using the average value of the total scores of the five panelists according to the following evaluation criteria.
<Score and details regarding skin moisture>
5 points: Skin feels very fresh and moisturized.
4 points: Skin feels slightly moist.
3 points: I can't say either way.
2 points: Skin feels a little dry.
1 point: My skin doesn't feel fresh or moisturized at all.
(Evaluation criteria for skin moisture)
◎: Very good (average score of 5 people was 4 points or more)
○: Good (the average score of the five participants was 3 points or more and less than 4 points)
△: Somewhat poor (the average score of the five participants was 2 points or more but less than 3 points)
×: Poor (the average score of 5 people was less than 2 points)
4.赤み改善効果測定
評価パネル10名について、本発明の実施例および比較例の皮膚化粧料組成物適量塗布を10日間連用で行った。連用前と連用後の試験部位を、色彩色差計(CM-700d:コニカミノルタ製)を用いて測定し、a*値を数値化した。赤み改善効果の評価は、以下の計算式より赤み減少率(%)を算出して5名の平均値を求め、赤み減少率が大きいほど赤み改善効果があることから、下記判断基準に基づいて行った。
<赤み改善効果に関する評点>
赤み減少率(%)=(連用後の肌のa*値/連用前の肌のa*値)×100
(赤み改善効果の評価基準)
◎:赤み減少率(%)が5%以上であった。
○:赤み減少率(%)が2.5%以上5%未満であった。
△:赤み減少率(%)が0%以上2.5%未満であった。
×:赤み減少率(%)が0%未満であった。
4. Redness Improvement Effect Measurement Ten evaluation panelists were subjected to continuous application of appropriate amounts of the skin cosmetic compositions of the Examples and Comparative Examples of the present invention for 10 days. The test sites before and after continuous application were measured using a color difference meter (CM-700d: manufactured by Konica Minolta) and the a* value was quantified. The redness improvement effect was evaluated based on the following criteria, with the redness reduction rate (%) calculated from the following formula and the average value of the five panelists being calculated. The greater the redness reduction rate, the greater the redness improvement effect.
<Score for redness improvement effect>
Redness reduction rate (%) = (a* value of skin after continuous use / a* value of skin before continuous use) x 100
(Evaluation criteria for redness improvement effect)
⊚: Redness reduction rate (%) was 5% or more.
Good: The redness reduction rate (%) was 2.5% or more and less than 5%.
Δ: The redness reduction rate (%) was 0% or more and less than 2.5%.
×: The redness reduction rate (%) was less than 0%.
5.ターンオーバー正常化効果測定
評価パネル10名について、本発明の実施例および比較例の皮膚化粧料組成物適量塗布を10日間連用で行った。連用前と連用後において、前腕部をぬるま湯で洗浄したのち、それぞれ温度25℃、相対湿度50%の環境下にて20分間馴化させた。次に前腕部の測定部位に、セロハンテープ(ニチバン製)4cm×2.5cmを貼付し、はがす操作を行った。この貼付→はがすの操作を5回繰り返して、角層を採取した。その後、剥がしたセロハンテープをマイクロスコープ(キーエンス社製、VHX-1000)にて観察した。ターンオーバー正常化効果は、「細胞形態」「多重剥離」「配列規律性」の3項目の点数それぞれを下記に示す5段階の評価で採点した。さらに、以下の計算式を用いて2項目の点数の合計値を算出し、下記評価基準に基づいて行った。その結果を表に示す。
<ターンオーバー正常化効果に関する評点>
ターンオーバー正常化効果(点)=(連用後の細胞形態、多重剥離及び配列規律性の評価
基準点)-(連用前の細胞形態、多重剥離及び配列規律性の評価基準点)
(細胞形態の評価基準点)
5点・・・細胞がはっきり五角形、または六角形である
4点・・・細胞にやや角が見られる
3点・・・細胞に角がほとんどない
2点・・・細胞がやや丸みを帯びている
1点・・・細胞が全体的に丸みを帯びている
(多重剥離の評価基準点)
5点・・・剥がした角層細胞のうち、細胞同士が重なっている細胞の割合が20%未満
4点・・・剥がした角層細胞のうち、細胞同士が重なっている細胞の割合が20%以上40%未満
3点・・・剥がした角層細胞のうち、細胞同士が重なっている細胞の割合が40%以上60%未満
2点・・・剥がした角層細胞のうち、細胞同士が重なっている細胞の割合が60%以上80%未満
1点・・・剥がした角層細胞のうち、細胞同士が重なっている細胞の割合が80%以上
(配列規律性の評価基準点)
5点・・・整然と隙間なく配列している細胞の割合が80%以上
4点・・・整然と隙間なく配列している細胞の割合が60%以上80%未満
3点・・・整然と隙間なく配列している細胞の割合が40%以上60%未満
2点・・・整然と隙間なく配列している細胞の割合が20%以上40%未満
1点・・・整然と隙間なく配列している細胞の割合が20%未満
(ターンオーバー正常化効果の評価基準)
◎:ターンオーバー正常化効果(点)が4点以上6点未満であった。
○:ターンオーバー正常化効果(点)が2点以上4点未満であった。
△:ターンオーバー正常化効果(点)が0点以上2点未満であった。
×:ターンオーバー正常化効果(点)が0点以下であった。
5. Measurement of turnover normalization effect Ten evaluation panel members were subjected to continuous application of appropriate amounts of the skin cosmetic compositions of the examples and comparative examples of the present invention for 10 days. Before and after continuous application, the forearms were washed with lukewarm water, and then allowed to acclimate for 20 minutes in an environment of 25°C and 50% relative humidity. Next, cellophane tape (manufactured by Nichiban) 4 cm x 2.5 cm was applied to the measurement site of the forearm and peeled off. This application-peel off operation was repeated five times to collect the stratum corneum. The peeled cellophane tape was then observed under a microscope (manufactured by Keyence Corporation, VHX-1000). The turnover normalization effect was scored in three items, "cell morphology,""multiplepeeling," and "arrangement regularity," on a five-level evaluation scale as shown below. Furthermore, the total score of the two items was calculated using the following formula, and the evaluation was performed based on the following criteria. The results are shown in the table.
<Score for turnover normalization effect>
Turnover normalization effect (points) = (evaluation standard points for cell morphology, multiple detachment, and regularity of cell arrangement after continuous use) - (evaluation standard points for cell morphology, multiple detachment, and regularity of cell arrangement before continuous use)
(Cell morphology evaluation criteria)
5 points: the cells are clearly pentagonal or hexagonal; 4 points: the cells have some corners; 3 points: the cells have almost no corners; 2 points: the cells are slightly rounded; 1 point: the cells are generally rounded (evaluation criteria for multiple detachment)
5 points: Less than 20% of the removed stratum corneum cells are overlapping; 4 points: Between 20% and less than 40% of the removed stratum corneum cells are overlapping; 3 points: Between 40% and less than 60% of the removed stratum corneum cells are overlapping; 2 points: Between 60% and less than 80% of the removed stratum corneum cells are overlapping; 1 point: Between 80% and more of the removed stratum corneum cells are overlapping (criteria for evaluation of arrangement regularity)
5 points: 80% or more of cells are arranged neatly and without gaps; 4 points: 60% or more but less than 80% of cells are arranged neatly and without gaps; 3 points: 40% or more but less than 60% of cells are arranged neatly and without gaps; 2 points: 20% or more but less than 40% of cells are arranged neatly and without gaps; 1 point: Less than 20% of cells are arranged neatly and without gaps (evaluation criteria for turnover normalization effect)
⊚: Turnover normalization effect (score) was 4 points or more and less than 6 points.
◯: Turnover normalization effect (points) was 2 points or more and less than 4 points.
Δ: Turnover normalizing effect (points) was 0 points or more and less than 2 points.
×: Turnover normalization effect (points) was 0 points or less.
6.バリア機能効果測定試験
5名のパネルの左右いずれかの前腕部に本発明の皮膚化粧料を、もう片方の前腕部に純水を、一日二回0.05mL/cm2塗布する連用試験を1週間行った。連用前及び連用後に、測定部位をぬるま湯で洗浄し、次に、温度25℃、相対湿度50%の環境下にて20分間馴化後、前腕部の角質層の経皮水分蒸散量(TEWL値)をtewameter(MPA580、Courage+Khazaka社製)を用いて測定した。TEWLの値を用いることで角層のバリア機能を確認することができ、荒れ肌改善効果や肌の滑らかさへの影響を検討することが可能である。バリア機能効果の評価は、以下の計算式よりバリア機能効果(%)を算出して5名の平均値を求め、下記判断基準に基づいて行った。
<バリア機能効果に関する評点と内容>
バリア機能効果(%)={1-(塗布後1時間経過時点での角質水分蒸散量/塗布前の角質水分蒸散量)}×100
(バリア機能効果測定試験の評価基準)
◎:バリア機能効果(%)が30%以上であった。
○:バリア機能効果(%)が10%以上30%未満であった。
△:バリア機能効果(%)が-10%以上10%未満であった。
×:バリア機能効果(%)が-10%未満であった。
6. Barrier function effect measurement test A continuous use test was conducted for one week in which the skin cosmetic of the present invention was applied to either the left or right forearm of five panels, and pure water was applied to the other forearm, twice a day at 0.05 mL/cm2. Before and after continuous use, the measurement site was washed with lukewarm water, and then, after 20 minutes of acclimation in an environment of 25°C and 50% relative humidity, the transepidermal water loss (TEWL value) of the stratum corneum of the forearm was measured using a tewameter (MPA580, Courage+Khazaka). The TEWL value can be used to confirm the barrier function of the stratum corneum, and it is possible to examine the effect of improving rough skin and the effect on skin smoothness. The barrier function effect was evaluated by calculating the barrier function effect (%) from the following formula to obtain the average value of the five panels, and based on the following criteria.
<Score and details regarding barrier function effect>
Barrier function effect (%) = {1 - (amount of moisture lost from stratum corneum one hour after application / amount of moisture lost from stratum corneum before application)} x 100
(Evaluation criteria for the barrier function effect measurement test)
⊚: Barrier function effect (%) was 30% or more.
Good: The barrier function effect (%) was 10% or more and less than 30%.
Δ: The barrier function effect (%) was −10% or more and less than 10%.
×: The barrier function effect (%) was less than −10%.
<実施例1~6および比較例1~4>
表1に示す実施例1~9および比較例1~6の各処方における皮膚化粧料組成物を常法により調整し、各試験法により評価した。その結果を表1に併せて示す。
<Examples 1 to 6 and Comparative Examples 1 to 4>
Skin cosmetic compositions having the respective formulations of Examples 1 to 9 and Comparative Examples 1 to 6 shown in Table 1 were prepared by ordinary methods and evaluated by the respective test methods. The results are also shown in Table 1.
表1、2から明らかなように、本発明の成分を用いた実施例の皮膚化粧料組成物はいずれも優れた性能を有していた。一方、必須成分のいずれかを欠いた比較例では、べたつきのなさ、肌のみずみずしさ、肌のうるおい、赤み改善効果、ターンオーバー正常化効果のいずれかの面で劣っており、本発明の目的を達成できなかった。 As is clear from Tables 1 and 2, all of the skin cosmetic compositions in the examples using the components of the present invention had excellent performance. On the other hand, the comparative examples lacking any of the essential components were inferior in terms of non-stickiness, skin freshness, skin moisture, redness improvement effect, and turnover normalization effect, and the objective of the present invention could not be achieved.
以下、本発明の皮膚化粧料組成物のその他の実施例を処方例として挙げる。なお、これらの処方例の皮膚化粧料組成物についても、上記のべたつきのなさ、肌のみずみずしさ、肌のうるおい、赤み改善効果、ターンオーバー正常化効果について各項目を検討したところ、いずれにおいても優れた特性を有しており良好であった。
Other examples of the skin cosmetic composition of the present invention are given below as formulation examples. The skin cosmetic compositions of these formulation examples were also examined for the above-mentioned non-stickiness, skin freshness, skin moisture, redness improvement effect, and turnover normalization effect, and were found to have excellent properties and be favorable in all respects.
処方例1(美容セラム) (質量%)
(1)アシタバ葉/茎エキス 0.4%
(2)ユズ果実抽出物 0.02%
(3)グルコシルトレハロース 0.01%
(4)パルミチン酸レチノール 0.1%
(5)アスコルビン酸2―グルコシド 3.0%
(6)L-アスコルビン酸硫酸エステル二ナトリウム 0.7%
(7)ビワ果実エキス 0.4%
(8)ローヤルゼリーエキス 2.0%
(9)ハトムギ種子エキス 0.01%
(10)レモン果実エキス 0.2%
(11)ジフェニルシロキシフェニルトリメチコン 0.8%
(12)トリメチルシロキシフェニルジメチコン 0.5%
(13)フェニルトリメチコン 0.1%
(14)シクロヘキサン-1,4-ジカルボン酸ビスエトキシジグリコール1.0%
(15)ポリエチレングリコール(平均分子量4000) 1.5%
(16)ポリグリセリン-6 3.0%
(17)メチルグルセス-20 2.0%
(18)グリセリン 10.0%
(19)ジプロピレングリコール 1.0%
(20)1,3-ブチレングリコール 0.5%
(21)EDTA-2Na 0.01%
(22)キサンタンガム 0.25%
(23)カルボキシビニルポリマー 0.1%
(24)アルキル変性カルボキシビニルポリマー 0.01%
(25)ヒドロキシエチルエチレンジアミン三酢酸三ナトリウム 0.001%
(26)PEG-60水添ヒマシ油 0.5%
(27)ポリソルベート20 0.1%
(28)クエン酸 0.02%
(29)クエン酸ナトリウム 0.04%
(30)香料 0.007%
(31)フェノキシエタノール 0.3%
(32)メチルパラベン 0.05%
(33)精製水 残部
Formulation Example 1 (Beauty Serum) (mass%)
(1) Angelica keiskei leaf/stem extract 0.4%
(2) Yuzu fruit extract 0.02%
(3) Glucosyltrehalose 0.01%
(4) Retinol palmitate 0.1%
(5) Ascorbic acid 2-glucoside 3.0%
(6) Disodium L-ascorbic acid sulfate 0.7%
(7) Loquat Fruit Extract 0.4%
(8) Royal Jelly Extract 2.0%
(9) Job's Tears Seed Extract 0.01%
(10) Lemon Fruit Extract 0.2%
(11) Diphenylsiloxyphenyl trimethicone 0.8%
(12) Trimethylsiloxyphenyl dimethicone 0.5%
(13) Phenyl trimethicone 0.1%
(14) Cyclohexane-1,4-dicarboxylic acid bisethoxydiglycol 1.0%
(15) Polyethylene glycol (average molecular weight 4000) 1.5%
(16) Polyglycerin-6 3.0%
(17) Methyl gluceth-20 2.0%
(18) Glycerin 10.0%
(19) Dipropylene glycol 1.0%
(20) 1,3-butylene glycol 0.5%
(21) EDTA-2Na 0.01%
(22) Xanthan gum 0.25%
(23) Carboxyvinyl polymer 0.1%
(24) Alkyl-modified carboxyvinyl polymer 0.01%
(25) Trisodium hydroxyethylethylenediaminetriacetate 0.001%
(26) PEG-60 hydrogenated castor oil 0.5%
(27) Polysorbate 20 0.1%
(28) Citric acid 0.02%
(29) Sodium citrate 0.04%
(30) Fragrance 0.007%
(31) Phenoxyethanol 0.3%
(32) Methylparaben 0.05%
(33) Purified water Balance
(製法)(11)~(33)を80℃まで加熱し、均一に溶解させた。その後、35℃まで冷却し、(1)~(10)を加え、均一に溶解させた後、容器に充填して美容セラムを調製した。 (Production method) (11) to (33) were heated to 80°C and dissolved uniformly. After that, they were cooled to 35°C, (1) to (10) were added, dissolved uniformly, and then the mixture was poured into a container to prepare the beauty serum.
処方例2(シートマスク) (質量%)
(1)アシタバ葉/茎エキス 1.0%
(2)ユズ果実抽出物 0.8%
(3)グルコシルトレハロース 1.0%
(4)グリシン 0.5%
(5)アラリアエスクレンタエキス 0.1%
(6)ローズ水 0.4%
(7)アスコルビン酸2-グルコシド 0.001%(8)セージ葉エキス 0.006%(9)ポリエチレングリコール(平均分子量1000) 0.5%
(10)ポリアクリル酸Na 1.5%
(11)ジプロピレングリコール 10.0%
(12)ニコチン酸アミド 0.01%
(13)アルキル変性カルボキシビニルポリマー 0.15%
(14)トリイソステアリン酸PEG-10グリセリル 0.1%
(15)(PCA/イソステアリン酸)PEG-40水添ヒマシ油 0.1%
(16)PEG-60水添ヒマシ油 0.1%
(17)リン酸一カリウム 0.09%
(18)リン酸二ナトリウム 0.01%
(19)メチルパラベン 0.005%(20)シクロヘキシルグリセリン 0.5%
(21)スクワラン 0.1%
(22)PEG-11メチルエーテルジメチコン 0.05%
(23)パルミチン酸エチルヘキシル 0.1%
(24)精製水 残部
Formulation Example 2 (Sheet Mask) (% by mass)
(1) Angelica keiskei leaf/stem extract 1.0%
(2) Yuzu fruit extract 0.8%
(3) Glucosyltrehalose 1.0%
(4) Glycine 0.5%
(5) Alaria Esculenta Extract 0.1%
(6) Rose water 0.4%
(7) Ascorbic acid 2-glucoside 0.001% (8) Sage leaf extract 0.006% (9) Polyethylene glycol (average molecular weight 1000) 0.5%
(10) Sodium polyacrylate 1.5%
(11) Dipropylene glycol 10.0%
(12) Nicotinamide 0.01%
(13) Alkyl-modified carboxyvinyl polymer 0.15%
(14) PEG-10 glyceryl triisostearate 0.1%
(15) (PCA/isostearic acid) PEG-40 hydrogenated castor oil 0.1%
(16) PEG-60 hydrogenated castor oil 0.1%
(17) Potassium phosphate monobasic 0.09%
(18) Disodium phosphate 0.01%
(19) Methylparaben 0.005% (20) Cyclohexylglycerin 0.5%
(21) Squalane 0.1%
(22) PEG-11 methyl ether dimethicone 0.05%
(23) Ethylhexyl palmitate 0.1%
(24) Purified water Balance
(製法)(1)~(20)、(24)を80℃に加熱、撹拌をして均一溶解させる(A液)。(21)~(23)を80℃に加熱、撹拌して均一に分散させる(B液)。A液にB液を加え、均一になるまでホモミキサーにて分散した後、30℃まで冷却して、美容液を作成する。その後、作成された美容液を不織布シートに含浸させて、シートマスクを調製した。 (Production method) (1)-(20) and (24) are heated to 80°C and stirred to dissolve uniformly (Liquid A). (21)-(23) are heated to 80°C and stirred to disperse uniformly (Liquid B). Liquid B is added to Liquid A and dispersed in a homogenizer until uniform, then cooled to 30°C to prepare the serum. The serum is then impregnated into a nonwoven fabric sheet to prepare a sheet mask.
処方例3(美白化粧下地クリーム) (質量%)
(1)アシタバエキス 0.005%(2)ユズセラミド 0.9%
(3)グリコシルトレハロース・水添デンプン分解物混合溶液 0.1%
(4)グリシン 8.0%
(5)オウゴン根エキス 0.75%
(6)ローズマリー葉エキス 0.005%(7)カミツレ花エキス 0.0003%(8)イタドリ根エキス 2.5%
(9)カンゾウ根エキス 5.0%
(10)アルテア根エキス 0.0007%(11)アロエベラ液汁 0.85%
(12)ウイキョウ果実エキス 1.0%
(13)コエンザイムQ10 0.001%(14)シクロヘキサン-1,4-ジカルボン酸ビスエトキシジグリコール0.75%
(15)グリチルリチン酸ジカリウム 0.05%
(16)アスコルビン酸2-グルコシド 2.0%
(17)トラネキサム酸 3.0%
(18)N-ステアロイル-L-グルタミン酸ナトリウム 0.5%
(19)モノイソステアリン酸ソルビタン 0.1%
(20)トリイソステアリン酸PEG-10グリセリル 0.2%
(21)PEG-60水添ヒマシ油 0.9%
(22)カルボキシビニルポリマー 0.1%
(23)キサンタンガム 0.01%
(24)疎水化ヒドロキシプロピルメチルセルロース 0.01%
(25)水酸化カリウム 0.02%
(26)L-アルギニン 0.01%
(27)クエン酸 0.01%
(28)リン酸2カリウム 0.04%
(29)トリエタノールアミン 0.02%
(30)エチルパラベン 0.05%
(31)メチルパラベン 0.05%
(32)フェノキシエタノール 0.5%
3-O-エチルアスコルビン酸 0.01%
(34)パルミチン酸レチノール 0.01%
(35)ニコチン酸dl-α-トコフェロール 0.05%
(36)ミネラルオイル 3.0%
(37)ミリスチン酸オクチルドデシル 2.0%
(38)スクワラン 1.0%
(39)トリ(カプリル・カプリン・ミリスチン・ステアリン酸)グリセリルグリセリル
0.5%
(40)酸化亜鉛 0.1%
(41)ジリノール酸ジ(フィトステリル/イソステアリル/セチル/ステアリル/ベヘニル) 0.3%
(42)サラシミツロウ 0.9%
(43)セチル硫酸ナトリウム 0.05%
(44)フェニルトリメチコン 0.3%
(45)ジフェニルトリメチコン 0.1%
(46)精製水 残部
Formulation Example 3 (Whitening makeup base cream) (mass %)
(1) Angelica keiskei extract 0.005% (2) Yuzu ceramide 0.9%
(3) Glycosyltrehalose/hydrogenated starch hydrolysate mixed solution 0.1%
(4) Glycine 8.0%
(5) Scutellaria baicalensis root extract 0.75%
(6) Rosemary Leaf Extract 0.005% (7) Chamomile Flower Extract 0.0003% (8) Japanese Knotweed Root Extract 2.5%
(9) Licorice Root Extract 5.0%
(10) Althea Root Extract 0.0007% (11) Aloe Vera Juice 0.85%
(12) Fennel Fruit Extract 1.0%
(13) Coenzyme Q10 0.001% (14) Cyclohexane-1,4-dicarboxylic acid bisethoxydiglycol 0.75%
(15) Dipotassium glycyrrhizinate 0.05%
(16) Ascorbic acid 2-glucoside 2.0%
(17) Tranexamic acid 3.0%
(18) Sodium N-stearoyl-L-glutamate 0.5%
(19) Sorbitan monoisostearate 0.1%
(20) PEG-10 glyceryl triisostearate 0.2%
(21) PEG-60 hydrogenated castor oil 0.9%
(22) Carboxyvinyl polymer 0.1%
(23) Xanthan gum 0.01%
(24) Hydrophobized hydroxypropyl methylcellulose 0.01%
(25) Potassium hydroxide 0.02%
(26) L-arginine 0.01%
(27) Citric acid 0.01%
(28) Dipotassium phosphate 0.04%
(29) Triethanolamine 0.02%
(30) Ethylparaben 0.05%
(31) Methylparaben 0.05%
(32) Phenoxyethanol 0.5%
3-O-Ethyl ascorbic acid 0.01%
(34) Retinol palmitate 0.01%
(35) dl-α-tocopherol nicotinate 0.05%
(36) Mineral oil 3.0%
(37) Octyldodecyl myristate 2.0%
(38) Squalane 1.0%
(39) Tri(caprylic/capric/myristic/stearic acid)glyceryl
0.5%
(40) Zinc oxide 0.1%
(41) Dilinoleic acid di(phytosteryl/isostearyl/cetyl/stearyl/behenyl) 0.3%
(42) Beeswax 0.9%
(43) Sodium cetyl sulfate 0.05%
(44) Phenyl trimethicone 0.3%
(45) Diphenyl trimethicone 0.1%
(46) Purified water Balance
(製法)(18)~(33)および(46)の一部を約80℃に加熱、撹拌をして均一溶解させる(A液)。(34)~(45)を約80℃に加熱、撹拌をして均一溶解させる(B液)。B液にA液を加えてホモミキサーにて分散する。ついで冷却を行い、40℃で(1)~(17)を(46)の残部に溶解させたものを添加してさらに均一溶解させる。再び30℃まで冷却して美白化粧下地クリームを調製した。 (Production method) (18)-(33) and a portion of (46) are heated to approximately 80°C and stirred until uniformly dissolved (Liquid A). (34)-(45) are heated to approximately 80°C and stirred until uniformly dissolved (Liquid B). Liquid A is added to Liquid B and dispersed using a homogenizer. The mixture is then cooled, and a solution of (1)-(17) in the remainder of (46) at 40°C is added and further dissolved uniformly. The mixture is cooled again to 30°C to prepare a whitening makeup base cream.
処方例4(ジェルクリーム) (質量%)
(1)アシタバ葉/茎エキス 0.5%
(2)ユズ果実抽出物 0.2%
(3)グルコシルトレハロース 0.005%(4)トラネキサム酸 2.0%
(5)マルトース・ショ糖縮合物 0.5%
(6)トリメチルグリシン 1.5%
(7)グルコシルセラミド 0.1%
(8)メチルグルセス-20 0.01%
(9)ピロリドンカルボン酸ナトリウム 0.1%
(10)エデト酸二ナトリウム 0.01%
(11)ポリエチレングリコール(分子量4000) 2.0%
(12)ベヘニルアルコール 1.0%
(13)ステアロイルグルタミン酸ナトリウム 0.3%
(14)カルボキシビニルポリマー 0.2%
(15)(アクリレーツ/アクリル酸アルキル(C10-30))クロスポリマー
0.2%
(16)HEDTA-3Na 0.005%(17)クエン酸 0.01%
(18)水酸化カリウム 0.22%
(19)ジプロピレングリコール 5.0%
(20)1,3-ブチレングリコール 10.0%
(21)モノステアリン酸グリセリル 2.0%
(22)ミリスチン酸オクチルドデシル 0.5%
(23)メチルポリシロキサン(6CS) 1.5%
(24)ミツロウ 1.0%
(25)セラミドIII 0.1%
(26)イソステアリン酸ソルビタン 0.2%
(27)純水 残部
Formulation Example 4 (gel cream) (mass %)
(1) Angelica keiskei leaf/stem extract 0.5%
(2) Yuzu fruit extract 0.2%
(3) Glucosyltrehalose 0.005% (4) Tranexamic acid 2.0%
(5) Maltose-sucrose condensate 0.5%
(6) Trimethylglycine 1.5%
(7) Glucosylceramide 0.1%
(8) Methyl gluceth-20 0.01%
(9) Sodium pyrrolidone carboxylate 0.1%
(10) edetate disodium 0.01%
(11) Polyethylene glycol (molecular weight 4000) 2.0%
(12) Behenyl alcohol 1.0%
(13) Sodium stearoyl glutamate 0.3%
(14) Carboxyvinyl polymer 0.2%
(15) (Acrylates/C10-30 alkyl acrylate) crosspolymer
0.2%
(16) HEDTA-3Na 0.005% (17) Citric acid 0.01%
(18) Potassium hydroxide 0.22%
(19) Dipropylene glycol 5.0%
(20) 1,3-butylene glycol 10.0%
(21) Glyceryl monostearate 2.0%
(22) Octyldodecyl myristate 0.5%
(23) Methylpolysiloxane (6CS) 1.5%
(24) Beeswax 1.0%
(25) Ceramide III 0.1%
(26) Sorbitan isostearate 0.2%
(27) Pure water Balance
(製法)(9)~(20)、(27)を80℃に加温し、均一溶解させた(A液)。(21)~(26)を均一溶解させた後に80℃に加温した(B液)。B液にA液を加え、ホモミキサーにて分散した後、室温まで冷却してジェルクリームを調製した。 (Production method) (9)-(20) and (27) were heated to 80°C and uniformly dissolved (Liquid A). (21)-(26) were uniformly dissolved and then heated to 80°C (Liquid B). Liquid A was added to Liquid B, and the mixture was dispersed using a homomixer, and then cooled to room temperature to prepare a gel cream.
処方例5(シワ隠しクリーム) (質量%)
(1)アシタバ葉/茎エキス 0.07%
(2)ユズ果実抽出物 0.7%
(3)グルコシルトレハロース 0.05%
(4)ダイズ種子エキス 0.5%
(5)絹加水分解物 0.3%
(6)ノイバラ果実エキス 0.0008%(7)キウイエキス 0.09%
(8)褐藻エキス 0.0001%(9)紅藻エキス 0.45%
(10)緑藻エキス 0.5%
(11)サッカロミセス/コメ発酵液 0.9%
(12)エタノール 15.0%
(13)ポリオキシエチレン(2)アルキル(12~15)リン酸 0.5%
(14)ポリオキシエチレン(2)オレイルエーテル 0.5%
(15)PEG-60水添ヒマシ油 0.5%
(16)ポリビニルピロリドン 0.1%
(17)カルボキシビニルポリマー 0.3%
(18)水酸化カリウム 0.15%
(19)エデト酸二ナトリウム 0.05%
(20)香料 0.1%
(21)フェノキシエタノール 0.2%
(22)流動パラフィン 5.0%
(23)チルポリシロキサン(100cs) 1.0%
(24)ワセリン 1.0%
(25)ジフェニルトリメチコン 1.5%
(26)精製水 残部
Formulation Example 5 (Wrinkle concealing cream) (mass %)
(1) Angelica keiskei leaf/stem extract 0.07%
(2) Yuzu fruit extract 0.7%
(3) Glucosyltrehalose 0.05%
(4) Soybean Seed Extract 0.5%
(5) Silk hydrolysate 0.3%
(6) Rosa multiflora fruit extract 0.0008% (7) Kiwi fruit extract 0.09%
(8) Brown algae extract 0.0001% (9) Red algae extract 0.45%
(10) Green Algae Extract 0.5%
(11) Saccharomyces/rice fermentation liquid 0.9%
(12) Ethanol 15.0%
(13) Polyoxyethylene (2) alkyl (12-15) phosphate 0.5%
(14) Polyoxyethylene (2) Oleyl ether 0.5%
(15) PEG-60 hydrogenated castor oil 0.5%
(16) Polyvinylpyrrolidone 0.1%
(17) Carboxyvinyl polymer 0.3%
(18) Potassium hydroxide 0.15%
(19) edetate disodium 0.05%
(20) Fragrance: 0.1%
(21) Phenoxyethanol 0.2%
(22) Liquid paraffin 5.0%
(23) Tylpolysiloxane (100cs) 1.0%
(24) Vaseline 1.0%
(25) Diphenyl trimethicone 1.5%
(26) Purified water Balance
(製法)(13)~(21)を(26)に加え、70℃に加熱して均一溶解させる(A液)。(22)~(25)を60℃に加熱して均一分散し、A液に加え、ホモミキサーにて分散する。次に(1)~(12)を加えて攪拌し、チューブ容器に充填し、ボディミルクを調製した。 (Production method) (13)-(21) are added to (26) and heated to 70°C until uniformly dissolved (Liquid A). (22)-(25) are heated to 60°C until uniformly dispersed, then added to Liquid A and dispersed using a homomixer. Next, (1)-(12) are added and stirred, and the mixture is filled into tube containers to prepare the body milk.
処方例6(キメ改善美容液) (質量%)
(1)アシタバ葉/茎エキス 1.0%
(2)ユズ果実抽出物 1.0%
(3)グルコシルトレハロース 1.0%
(4)コンドロイチン硫酸ナトリウム 0.7%
(5)アスコルビン酸2-グルコシド 0.01%
(6)加水分解エラスチン 0.5%
(7)α-グルカンオリゴサッカリド 0.3%
(8)キュウリ果実エキス 0.2%
(9)セイヨウキズタエキス 0.1%
(10)セイヨウニワトコエキス 0.5%
(11)パリエタリアエキス 0.75%
(12)アルニカ花エキス 0.3%
(13)乳酸桿菌/セイヨウナシ果汁発酵液 0.5%
(14)ブドウ葉エキス 0.2%
(15)セイヨウオトギリソウ花/葉/茎エキス 0.1%
(16)ハマメリス葉エキス 0.2%
(17)セイヨウトチノキ葉エキス 0.5%
(18)フユボタイジュエキス 0.004%(19)トウキンセンカ花エキス 0.25%
(20)ヤグルマギク花エキス 0.1%
(21)ローマカミツレ花エキス 0.0001%(22)モモ葉エキス 0.0005%(23)シクロヘキサン―1,4―ジカルボン酸ビスエトキシジグリコール0.6%
(24)(アクリル酸Na/アクリロイルジメチルタウリンNa)コポリマー0.6%
(25)ポリクオタニウムー52 0.2%
(26)POE(60)硬化ヒマシ油 0.1%
(27)1,3-ブチレングリコール 6.0%
(28)グリセリン 5.0%
(29)ポリエチレングリコール4000 1.0%
(30)ソルビトール 3.0%
(31)マルチトール 3.0%
(32)ジイソプロパノールアミン 0.05%
(33)水酸化カリウム 0.05%
(34)カルボキシビニルポリマー 0.1%
(35)アルキル変性カルボキシビニルポリマー 0.12%
(36)キサンタンガム 0.05%
(37)エデト酸二ナトリウム 0.01%
(38)ピロ亜硫酸Na 0.005%(39)ミリスチン酸オクチルドデシル 1.0%
(40)コレステロール 0.5%
(41)精製水 残部
Formulation Example 6 (texture improving serum) (mass %)
(1) Angelica keiskei leaf/stem extract 1.0%
(2) Yuzu Fruit Extract 1.0%
(3) Glucosyltrehalose 1.0%
(4) Sodium chondroitin sulfate 0.7%
(5) Ascorbic acid 2-glucoside 0.01%
(6) Hydrolyzed elastin 0.5%
(7) α-glucan oligosaccharide 0.3%
(8) Cucumber Fruit Extract 0.2%
(9) English Ivy Extract 0.1%
(10) Elderberry Extract 0.5%
(11) Parietaria Extract 0.75%
(12) Arnica Flower Extract 0.3%
(13) Lactobacillus/fermented pear juice filtrate 0.5%
(14) Grape Leaf Extract 0.2%
(15) Hypericum perforatum flower/leaf/stem extract 0.1%
(16) Hamamelis virginiana leaf extract 0.2%
(17) Horse Chestnut Leaf Extract 0.5%
(18) Tilia japonica Extract 0.004% (19) Calendula officinalis flower extract 0.25%
(20) Centauer Flower Extract 0.1%
(21) Roman chamomile flower extract 0.0001% (22) Peach leaf extract 0.0005% (23) Cyclohexane-1,4-dicarboxylate bisethoxydiglycol 0.6%
(24) (Sodium acrylate/sodium acryloyldimethyltaurate) copolymer 0.6%
(25) Polyquaternium-52 0.2%
(26) POE (60) hydrogenated castor oil 0.1%
(27) 1,3-butylene glycol 6.0%
(28) Glycerin 5.0%
(29) Polyethylene glycol 4000 1.0%
(30) Sorbitol 3.0%
(31) Maltitol 3.0%
(32) Diisopropanolamine 0.05%
(33) Potassium hydroxide 0.05%
(34) Carboxyvinyl polymer 0.1%
(35) Alkyl-modified carboxyvinyl polymer 0.12%
(36) Xanthan gum 0.05%
(37) edetate disodium 0.01%
(38) Sodium pyrosulfite 0.005% (39) Octyldodecyl myristate 1.0%
(40) Cholesterol: 0.5%
(41) Purified water Balance
(製法)(1)~(38)、(41)を80℃にて均一溶解し、(39)、(40)を80℃にて均一分散したところへ入れ、ホモミキサーにて分散したのち冷却し、美容液を調製した。 (Production method) (1) to (38) and (41) were uniformly dissolved at 80°C, and (39) and (40) were added to the mixture, which was then uniformly dispersed at 80°C. The mixture was then dispersed using a homomixer and cooled to prepare the serum.
処方例7(サンスクリーン) (質量%)
(1)アシタバ葉/茎エキス 0.5%
(2)ユズ果実抽出物 0.2%
(3)グルコシルトレハロース 1.0%
(4)エタノール 15.0%
(5)ジプロピレングリコール 2.0%
(6)メトキシケイ皮エチルヘキシル 6.0%
(7)ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 1.0%
(8)ビスエチルヘキシルオキシフェノールメトキシフェニルトリアジン 1.0%
(9)t-ブチルメトキシジベンゾイルメタン 6.0%
(10)オクテニルコハク酸デンプンAl 0.2%
(11)POE・POP変性ジメチルポリシロキサン 1.0%
(12)ミリスチン酸オクチルドデシル 5.0%
(13)イソノナン酸イソノニル 1.0%
(14)メチルシクロポリシロキサン 1.0%
(15)ジメチルポリシロキサン 1.0%
(16)水添レシチン 0.08%
(17)フィトステロール 0.08%
(18)酢酸DL-α―トコフェロール 0.1%
(19)オウゴン根エキス 0.5%
(20)チャ葉エキス 0.005%(21)トウキ根エキス 0.002%(22)ローヤルゼリーエキス 0.9%
(23)水溶性コラーゲン 0.001%(24)アロエベラ葉エキス 0.01%
(25)シラカンバ樹皮エキス 0.1%
(26)セラミドNG 0.35%
(27)アセチルグルコサミン 0.2%
(28)ベントナイト 0.1%
(29)ジステアルジモニウムヘクトライト 0.1%
(30)シリカ被覆酸化亜鉛 5.0%
(31)精製水 残余
Formulation Example 7 (Sunscreen) (mass %)
(1) Angelica keiskei leaf/stem extract 0.5%
(2) Yuzu fruit extract 0.2%
(3) Glucosyltrehalose 1.0%
(4) Ethanol 15.0%
(5) Dipropylene glycol 2.0%
(6) Ethylhexyl methoxycinnamate 6.0%
(7) Diethylaminohydroxybenzoylhexyl benzoate 1.0%
(8) Bisethylhexyloxyphenol methoxyphenyl triazine 1.0%
(9) t-Butyl methoxydibenzoylmethane 6.0%
(10) Starch octenylsuccinate aluminum 0.2%
(11) POE/POP modified dimethylpolysiloxane 1.0%
(12) Octyldodecyl myristate 5.0%
(13) Isononyl isononanoate 1.0%
(14) Methylcyclopolysiloxane 1.0%
(15) Dimethylpolysiloxane 1.0%
(16) Hydrogenated lecithin 0.08%
(17) Phytosterol 0.08%
(18) DL-α-tocopherol acetate 0.1%
(19) Scutellaria Root Extract 0.5%
(20) Tea Leaf Extract 0.005% (21) Angelica acutiloba Root Extract 0.002% (22) Royal Jelly Extract 0.9%
(23) Water-soluble collagen 0.001% (24) Aloe vera leaf extract 0.01%
(25) Betula platyphylla bark extract 0.1%
(26) Ceramide NG 0.35%
(27) Acetyl glucosamine 0.2%
(28) Bentonite 0.1%
(29) Disteardimonium hectorite 0.1%
(30) Silica-coated zinc oxide 5.0%
(31) Purified water, balance
(製法)(1)~(3)を80℃に加熱した(31)に加えて溶解する(A液)。(5)、(16)~(29)を加え、80℃に加熱して均一に分散させる(B液)。(6)~(15)を70℃に加熱して均一溶解させる(C液)。A液にB液およびC液を順に加え、ホモミキサーで均一に混合させた後に、50℃まで冷却する。そこに(4)、(10)を加え、ホモミキサーでさらに均一に混合させた後、冷却してサンスクリーンを得た。
(Production method) (1) to (3) are added to (31) heated to 80°C and dissolved (Liquid A). (5) and (16) to (29) are added and heated to 80°C to disperse uniformly (Liquid B). (6) to (15) are heated to 70°C to dissolve uniformly (Liquid C). Liquids B and C are added to Liquid A in that order, mixed uniformly using a homomixer, and then cooled to 50°C. (4) and (10) are added thereto, further mixed uniformly using a homomixer, and then cooled to obtain a sunscreen.
Claims (3)
(A)アシタバ抽出物
(B)ユズ果実抽出物
(C)グルコシルトレハロース A skin cosmetic composition comprising the following (A) to (C):
(A) Angelica keiskei extract (B) Yuzu fruit extract (C) Glucosyl trehalose
The stickiness-reducing agent for skin cosmetics according to (A) and/or (B), which contains the component (C) as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022189734A JP2024077661A (en) | 2022-11-29 | 2022-11-29 | Skin cosmetic composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022189734A JP2024077661A (en) | 2022-11-29 | 2022-11-29 | Skin cosmetic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2024077661A true JP2024077661A (en) | 2024-06-10 |
Family
ID=91377377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022189734A Pending JP2024077661A (en) | 2022-11-29 | 2022-11-29 | Skin cosmetic composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2024077661A (en) |
-
2022
- 2022-11-29 JP JP2022189734A patent/JP2024077661A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1761450B (en) | Skin external preparation characterized by containing saccharide derivative of alpha, alpha-trehalose | |
EP2370052B1 (en) | Novel sebum secretion inhibitory agent | |
JP2012041302A (en) | Skin cosmetic | |
JP4091824B2 (en) | Skin preparation | |
JP2013107862A (en) | Skin cosmetic gel | |
JP2020180103A (en) | Wrinkle-improving composition | |
JP3987793B2 (en) | Topical skin preparation | |
JP4088497B2 (en) | Cosmetics | |
JP2017193506A (en) | Skin cosmetics | |
JP7305161B2 (en) | skin cosmetics | |
JP5226200B2 (en) | Sulfated glycosaminoglycan production promoter and skin external preparation containing the same | |
WO1999022709A1 (en) | Cosmetics and process for the preparation of extract of the nest of $i(oceanodroma sp.) | |
JP2021088523A (en) | Skin cosmetics | |
JP2005247826A (en) | Decorin production-promoting agent and skin care preparation for external use containing the same | |
JP6957228B2 (en) | Beauty method | |
JP5000964B2 (en) | Testosterone 5α-reductase activity inhibitor, androgen receptor antagonist, use thereof, and method for suppressing androgen activity expression | |
JP2024077661A (en) | Skin cosmetic composition | |
JP4365281B2 (en) | DFA-containing external preparation for skin, cosmetics, ophthalmic solution | |
JP2005089427A (en) | Skin care preparation for external use | |
JP2002145754A (en) | Skin cosmetic | |
JP2009234976A (en) | Cell activator and external preparation for skin for antiaging | |
JP2021185879A (en) | Yeast culture extract and skin preparation containing the same | |
JP7523963B2 (en) | Skin cosmetics | |
JP2024003819A (en) | skin cosmetics | |
JP7608217B2 (en) | Composition for topical application to the skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20240325 |